Luis Cano

Director of Pathology @OWKIN

Paris, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2024 — Present

Director of Pathology @OWKIN

View department →

Paris, FR

EDUCATION

2012 — 2015

Universidad Nacional Mayor de San Marcos

Pathology Fellowship

2016 — 2019

Université de Rennes I

Doctor of Philosophy, Oncology and Cancer Biology

2012 — 2015

Universidad Nacional Mayor de San Marcos

Medico especialista en Anatomía Patológica, Residencia en Patología

2016

Université de Rennes I

Doctor of Philosophy - PhD, PHD student - VAS

2004 — 2011

Universidad Privada San Pedro

Doctor of Medicine (MD), Medicina

2004 — 2010

Universidad "San Pedro"

Doctor of Medicine, Medicine

SKILLS

Microsoft PowerpointPlanificación EstratégicaCiencias NaturalesMacroscopiaAsistencia SanitariaRHistologíaMedicinaAnálisis De ImágenesMicrosoft OfficePatologíaMicrosoft WordInmunohistoquímicaMicrosoft ExcelOncologíaInvestigaciónMicroscopio ÓpticoInvestigación ClínicaInglésServicio De Atención Al ClienteHospitalesInvestigación Y Desarrollo

ABOUT LUIS CANO

Imagine this scenario: A pathologist examines a complex tissue sample. In their hands lies the responsibility of a diagnosis that will change a patient’s life. With a traditional microscope, some subtle features might go unnoticed. But what if we could see beyond the visible? This is the revolution in digital pathology and artificial intelligence that I am leading. With 10 years of experience as a pathologist specializing in oncology—including leadership roles at Sanofi and Owkin—I have been at the intersection where clinical expertise meets cutting-edge technology. I have witnessed three transformative realities: Digital pathology does not replace the pathologist; it empowers them to see patterns and connections invisible to the human eye. Behind every algorithm and spatial analysis, there is a human story: a patient waiting for answers. True innovation happens when we combine deep knowledge of tumor biology with the analytical power of AI. My Approach: Three Fundamental Pillars Enhanced Precision → Leveraging spatial analysis and advanced tumor characterization techniques to achieve more accurate diagnoses and personalized treatments. 🤝 Multidisciplinary Collaboration → Building bridges between pathologists, oncologists, bioinformaticians, and AI experts to develop solutions that truly impact patient care. Knowledge Translation → Transforming complex data into actionable insights that both doctors and patients can understand and utilize. I specialize in digital pathology, translational oncology, spatial biology, and AI-powered biomarker discovery. My experience includes diagnostic strategy, medical affairs collaboration, and cross-functional innovation across pharma and medtech environments. At the core of my work is the belief that the most advanced technology must serve a deeply human purpose: improving lives. Every pixel analyzed, every algorithm developed, every biomarker identified has one ultimate goal: better outcomes for patients. Let’s Connect If you work in oncology, pathology, medical technologies, or AI in healthcare, let’s build a future where AI and digital pathology not only improve diagnostics but transform lives. Currently open to new opportunities in digital pathology, translational oncology, and strategic medical roles across pharma, biotech, or AI-driven diagnostics.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Luis Cano — Director of Pathology at OWKIN in Paris, FR | Unifers